DMAC vs IT
DiaMedica Therapeutics Inc (DMAC) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
DMAC currently screens at market cap $157.4M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the DMAC and IT stock pages for the full models.
Not investment advice.